Federation des caisses Desjardins du Quebec’s Catalyst Pharmaceutical CPRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.77K	Buy	247 +80	+48%	+$2.36K	﹤0.01%	2482
2026 Q1	$4.15K	Buy	+167	New	+$3.98K	﹤0.01%	2544
2023 Q4	–	Sell	-42	Closed	-$491	–	2390
2023 Q3	$491	Sell	42 -148	-78%	-$1.98K	﹤0.01%	2209
2023 Q2	$2.55K	Buy	+190	New	+$2.73K	﹤0.01%	2029

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's CPRX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Catalyst Pharmaceutical (CPRX) stake by 48% in Q2 2026, buying an estimated $2.36K and bringing the position to 247 shares worth $7.77K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

Federation des caisses Desjardins du Quebec first reported a position in CPRX in Q2 2023 and has held it in 4 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Federation des caisses Desjardins du Quebec held 247 shares of Catalyst Pharmaceutical worth $7.77K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 80 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.36K.
Catalyst Pharmaceutical made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2482 holding.
Federation des caisses Desjardins du Quebec first reported a position in Catalyst Pharmaceutical in Q2 2023 and has held it in 4 quarters since.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.